11/18
08:07 am
fbio
Fortress Biotech, Inc. (NASDAQ: FBIO) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
Low
Report
Fortress Biotech, Inc. (NASDAQ: FBIO) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
11/17
07:46 am
fbio
Fortress Biotech Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Medium
Report
Fortress Biotech Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
11/16
12:08 am
fbio
Fortress Biotech, Inc. (NASDAQ: FBIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Fortress Biotech, Inc. (NASDAQ: FBIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/14
08:59 pm
fbio
Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer [Yahoo! Finance]
High
Report
Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer [Yahoo! Finance]
11/14
04:27 pm
fbio
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
11/14
04:10 pm
fbio
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Medium
Report
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
9/26
08:30 am
fbio
Fortress Biotech to Participate in October 2024 Investor Conferences
Medium
Report
Fortress Biotech to Participate in October 2024 Investor Conferences
9/20
08:30 am
fbio
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
High
Report
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
9/4
08:30 am
fbio
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference